FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE)

Q1 2014 13F Holders as of 31 Mar 2014

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 114,331,829
Number of holders: 21
Total 13F shares, excl. options: 9,563,610
Shares change: +3,149,331
Total reported value, excl. options: $92,835,964
Value change: +$30,694,357
Number of buys: 10
Number of sells: -8
Price: $9.74

Significant Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q1 2014

23 filings reported holding FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share as of Q1 2014.
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 9,563,610 shares of 114,331,829 outstanding shares and own 8.4% of the company stock.
Largest 10 shareholders include FMR LLC (3,053,673 shares), Polaris Venture Management Co. V, L.L.C. (2,473,186 shares), WELLINGTON MANAGEMENT CO LLP (1,121,180 shares), KINGDON CAPITAL MANAGEMENT, L.L.C. (1,113,475 shares), ORBIMED ADVISORS LLC (692,900 shares), Board of Trustees of The Leland Stanford Junior University (303,538 shares), FARALLON CAPITAL MANAGEMENT LLC (275,000 shares), PRINCIPAL FINANCIAL GROUP INC (204,000 shares), VANGUARD GROUP INC (148,606 shares), and Bank of New York Mellon Corp (38,400 shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.